Press Release

April 1, 2016

Bravado Health Earns Electronic Prescribing of Controlled Substances Certification for ScriptRx

E-Prescribing/Electronic Prescribing of Controlled Substances (EPCS)

Bravado Health announces it again has earned Drummond Group certification for its ScriptRx electronic prescribing of controlled substances (EPCS) software applications. To earn certification, Bravado Health’s application was audited to ensure that it complied with the requirements delineated in the Drug Enforcement Administration’s (DEA) EPCS Final Rule (Interim), 21 CFR Part 1300, 1304, 1306, and 1311. Drummond Group’s EPCS certification process, one of the first approved by the DEA, is designed to review prescriber and pharmacy applications with EPCS extensions for compliance against the DEA EPCS Final Rule.

The audit is a requirement before prescribers or pharmacies can begin to exchange e-prescriptions with controlled substances (EPCS). Furthermore, it allows application vendors to make available to prescribers and pharmacies solutions that meet New York’s state mandate for paperless e-prescriptions (including controlled substances), which went into effect March 27, 2016.

“Given our previous experience with Drummond Group, we felt well-prepared for the biennial audit,” said David Turner, SVP and Chief Technology Officer at Bravado Health. “Drummond Group’s attention to the details of the DEA EPCS regulations, and their certification process allows us to implement our EPCS software with great confidence.”

“At Drummond Group, we ensure the EPCS certification process is carried out with integrity and strict interpretation to the regulations,” said Aaron Gomez, Drummond Group’s EPCS Program Director and Chief Scientist. “Being one of the first certification organizations to have an EPCS certification process reviewed and approved by DEA (approved July 2012), we take our responsibility seriously knowing there is a lot of confusion in the marketplace when it comes to EPCS certification. We provide depth in understanding the regulations; for example, which certificate authorities or credential providers are approved, and what does the ‘processing integrity’ clarification published by DEA mean and how it may apply.”

Additional information on Drummond Group’s EPCS certification program is available at

About Bravado Health
Bravado Health is a nationally-recognized leader in software development and management services for the ambulatory healthcare sector, including hospital emergency departments, urgent care centers, and retail health clinics. Bravado Health licenses and operates point-of-care applications in health systems throughout the United States. For additional information, please visit

About Drummond Group
Drummond Group is a global software test and certification lab that serves a wide range of vertical industries. In healthcare, Drummond Group tests and certifies Controlled Substance Ordering Systems (CSOS), Electronic Prescription of Controlled Substances (EPCS) software and processes, and Electronic Health Records (EHRs) – designating the trusted test lab as the only third-party certifier of all three initiatives designed to move the industry toward a digital future. Founded in 1999, and accredited for the Office of the National Coordinator Health IT Certification Program as an Authorized Certification Body (ACB) and an Accredited Test Lab (ATL), Drummond Group continues to build upon its deep experience and expertise necessary to deliver reliable and cost-effective services. For more information, please visit or email

Bravado Health
Shane Andreasen, Director of Marketing
561-805-5935 x125

Media Contacts

Shane Andreasen

Bravado Health

Bravado Health Media Line

(561) 805-5935